International Vaccine Institute

Grantee Website Seoul, Korea, Republic of
Purpose
to support the process development and scale up activities at SK Chemicals for the development of Vi-DT conjugate vaccine to support a large scale immunogenicity clinical trial (P3) and WHO PQ of the vaccine in the 2020-2022 timeframe.
Division
Global Health
Year Awarded
2018
Region Served
GLOBAL
Committed Amount
$4,999,977
Grant Topic
Enteric and Diarrheal Diseases
Duration (Months)
70
Grantee Location
Seoul, Korea, Republic of

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.